About Us

Dedicated to protect the unborn fetus:

More than 90% of pregnancies continue towards a healthy outcome. However, to have a normal pregnancy one must have a retrospective diagnosis for the same and this invariable may be associated with multiple questions from both the parents and close family members. Hence pre-natal screening in several forms allows early prediction of possible problems which may or may not be genetic/inherited. Cases are thus segregated as either high risk or low risk pregnancies at our fetal medicine center in Amritsar and with the aid of specialized FMF- UK accredited software we are able to offer the  surveillance required on an individual basis.

Maintained international standards of fetal care.

First trimester screening is a combination of fetal ultrasound and maternal blood tests. The ultrasound is done between 11- 13 +6 weeks and is performed by a FMF accredited operator. The blood testis performed on FMF approved bio-chemical assay systems and measures two hormones, beta- HCG and PAPP-A.
The combination of the nuchal translucency and the blood test is known as the combined first trimester screening test which has a 93% sensitivity in predicting the risk of chromosomal abnormalities, the most common of which is Down syndrome.

We follow the FMF-UK and ISUOG guidelines in all practice:

A specific set of guidelines has been formulated for performing the nuchal translucency, cervical, anomaly and fetal well being scans including fetal Dopplers. Your scan will be performed as per guidelines by an operator certified by the Fetal medicine Foundation-UK. Our aim is to offer best quality work to be able to calculate the risks for aneuploidies (chromosomal abnormalities) and prognosticate the pregnancy for the risk of pre-eclampsia and/or pre-term labour in order to continue a stress free pregnancy both for the mother and the Obstetrician!

The need for a CVS or an Amniocentesis

The results of the first trimester combined screening test are available in a weeks time. It provides us with the risks (probability) for the fetus having any chromosomal abnormality. As a guideline, an invasive prenatal test in the form of CVS (chorionic villous sampling) 10-12 weeks or amniocentesis, beyond 16 weeks is offered as a diagnostic test if the risks are higher than 1 in 150. Though these tests carry a risk of miscarriage, 0.5-1%, they are 100% diagnostic for certain chromosomal abnormalities. It is for you to decide whether or not the risk of having a chromosomal abnormality is high enough to warrant having an invasive test.